The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
An ill young man appealed for financial help to seek medical treatment. Brian Lang'at was diagnosed with pancreatic cyst that ...
Bizengri 20 mg/mL Injection for Intravenous Use is expected ... In patients with NRG1+ pancreatic adenocarcinoma (n=30), Bizengri demonstrated an ORR of 40%. DOR in NRG1+ pancreatic adenocarcinoma ...
There can be unpredictable side effects from taking uncertified weight loss jabs because the medicines will not have been ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 ...
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...